Participants 48 73 5
symptomatic endometriosis
Participants 143 249 4
endometriosis patients of a 12-month course of GnRH agonist alone or with one of three "add-back" regimens
Participants 369 421 3
All patients had received monthly leuprolide acetate
Participants 678 797 7
201 patients enrolled in the initial trial, 123 completed at least 280 days of therapy and entered the follow-up period
